While the links between metabolic dysfunction associated steatotic liver disease liver
disease (MASLD) and obesity, insulin resistance are widely appreciated, there are a host of …

Secondary nonalcoholic fatty liver disease (NAFLD) defines those complex
pathophysiological and clinical consequences that ensue when the liver becomes an …

Non-alcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease
in the world. It is linked mainly to insulin resistance and metabolic syndrome including …

Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease.
NAFLD often occurs associated with endocrinopathies. Evidence suggests that endocrine …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
in the industrialized world. NAFLD encompasses a whole spectrum ranging from simple …

Nonalcoholic fatty liver disease (NAFLD) has emerged as the most frequent chronic liver
disease globally. NAFLD is strongly associated with metabolic syndrome and it has been …

Factors such as aging, an unhealthy lifestyle with decreased physical activity, snacking, a
standard Western diet, and smoking contribute to raising blood pressure to a dangerous …

ABSTRACT Introduction Metabolic syndrome (MetS), ie the cluster of cardiometabolic risk
factors comprising visceral obesity, impaired glucose metabolism, arterial hypertension and …

Purpose In both preclinical and clinical settings, testosterone treatment (TTh) of
hypogonadism has shown beneficial effects on insulin sensitivity and visceral and liver fat …

Hyperandrogenemia (HA) is a hallmark of polycystic ovary syndrome (PCOS) and is an
integral element of non-alcoholic fatty liver disease (NALFD) in females. Administering low …